第一类MK4抑制剂增强肝脏再生并预防肝脏衰竭

Stefan Zwirner1, Anan A Abu Rmilah2, Sabrina Klotz3

  • 1Department of Medical Oncology and Pneumology (Internal Medicine VIII), University Hospital Tübingen, Tübingen 72076, Germany; HepaRegeniX GmbH, Tübingen 72072, Germany.

Cell
|March 15, 2024
PubMed
概括

针对MK4 (MKK4i) 的新型小分子抑制剂促进肝细胞再生. 这种方法改善了动物模型中的肝功能,并在早期人体试验中显示出肝病和手术后恢复的前景.